Richard D. Mamelok

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy (2009)

Ekberg, Henrik, Mamelok, Richard D, Oppenheimer, Federico, Sánchez-Plumed, Jaime, Gentil, Miguel Angel, ...

BACKGROUND: Exposure to mycophenolic acid (MPA), the primary active metabolite of mycophenolate mofetil (MMF), is correlated with therapeutic efficacy of MMF but varies depending on the concomitantly...

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy (2009)

Grinyó, Josep M., Ekberg, Henrik, Mamelok, Richard D., Oppenheimer, Federico, Sánchez-Plumed, Jaime, Gentil, Miguel Angel, ...

Background. Exposure to mycophenolic acid (MPA), the primary active metabolite of mycophenolate mofetil (MMF), is correlated with therapeutic efficacy of MMF but varies depending on the concomitantly...

Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial (2008)

Van Gelder, Tuen, Silva, Helio Tedesco, De Fijter, Johan W., Budde, Klemens, Kuypers, Dirk, Tyden, Gunna, ...

Therapeutic drug monitoring of mycophenolate mofetil in transplantation (2006)

Le Meur, Yann, Shaw, Leslie M, Oellerich, Michael, DeNofrio, David, Holt, Curtis, ...

A roundtable meeting to discuss the use of therapeutic drug monitoring (TDM) to guide immunosuppression with mycophenolate mofetil was held in New York in December 2004. Existing recommendations for...

Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion

Anaissie, Elias J., Mattiuzzi, Gloria N., Miller, Carole B., Noskin, Gary A., Gurwith, Marc J., Mamelok, Richard D., ...

Amphotericin B colloidal dispersion (ABCD) is a new formulation of conventional amphotericin B designed to minimize drug distribution in the kidney and reduce nephrotoxicity. We studied the safety...

Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion

Anaissie, Elias J., Mattiuzzi, Gloria N., Miller, Carole B., Noskin, Gary A., Gurwith, Marc J., Mamelok, Richard D., ...

Amphotericin B colloidal dispersion (ABCD) is a new formulation of conventional amphotericin B designed to minimize drug distribution in the kidney and reduce nephrotoxicity. We studied the safety...

Time-dependent clearance of mycophenolic acid in renal transplant recipients

Van Hest, Reinier M, Van Gelder, Teun, Bouw, René, Goggin, Timothy, Gordon, Robert, Mamelok, Richard D, ...